Norges Bank Ab Cellera Biologics Inc. Transaction History

Norges Bank

$772 Billion
Q2 2025

A detailed history of Norges Bank transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Norges Bank holds 630,938 shares of ABCL stock, worth $2.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

630,938

Holding current value

$2.69 Million

% of portfolio

0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$1.93 - $3.8 $1.22 Million - $2.4 Million	630,938 New	630,938 $2.16 Million
Q4 2024 Feb 12, 2025	BUY	$2.48 - $3.15 $3.19 Million - $4.05 Million	1,284,533 New	1,284,533 $3.76 Million
Q2 2024 Aug 14, 2024	BUY	$2.73 - $4.73 $2.52 Million - $4.36 Million	922,214 New	922,214 $2.73 Million
Q1 2024 May 14, 2025	BUY	$4.29 - $5.97 $3.96 Million - $5.51 Million	922,214 New	922,214 $4.18 Million
Q4 2023 Feb 09, 2024	BUY	$3.91 - $5.93 $3.61 Million - $5.47 Million	922,214 New	922,214 $5.27 Million
Q3 2023 Nov 13, 2024	BUY	$4.6 - $7.95 $4.24 Million - $7.33 Million	922,214 New	922,214 $4.24 Million
Q3 2023 Nov 13, 2023	SELL	$4.6 - $7.95 $2.4 Million - $4.15 Million	-522,410 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$5.66 - $7.59 $3.7 Million - $4.96 Million	653,447 Added 70.86%	1,575,661 $10.2 Million
Q2 2023 Aug 14, 2023	SELL	$5.66 - $7.59 $1.62 Million - $2.17 Million	-285,369 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$7.31 - $11.18 $11.5 Million - $17.6 Million	1,575,661 New	1,575,661 $11.9 Million
Q4 2022 Feb 14, 2023	BUY	$9.48 - $14.52 $6.13 Million - $9.39 Million	646,699 New	646,699 $6.55 Million
Q3 2022 Nov 13, 2023	BUY	$9.2 - $13.68 $4.81 Million - $7.15 Million	522,410 New	522,410 $5.17 Million
Q2 2022 Aug 14, 2023	BUY	$5.72 - $10.65 $1.63 Million - $3.04 Million	285,369 New	285,369 $3.04 Million
Q1 2022 May 12, 2023	SELL	$7.46 - $14.14 $2.7 Million - $5.11 Million	-361,330 Reduced 55.87%	285,369 $2.78 Million
Q1 2022 May 09, 2022	SELL	$7.46 - $14.14 $2.13 Million - $4.04 Million	-285,369 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$12.99 - $17.73 $3.71 Million - $5.06 Million	285,369 New	285,369 $4.08 Million
Q3 2021 Nov 14, 2022	BUY	$14.85 - $21.34 $1.78 Million - $2.56 Million	120,194 New	120,194 $2.41 Million
Q3 2021 Nov 05, 2021	SELL	$14.85 - $21.34 $742,500 - $1.07 Million	-50,000 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$20.19 - $34.17 $1.01 Million - $1.71 Million	50,000 New	50,000 $1.1 Million

Others Institutions Holding ABCL

# of Institutions

148

Shares Held

114M

Call Options Held

488K

Put Options Held

476K

Baker Bros. Advisors LP New York, NY

27.5M
Shares

$118 Million
0.96% of portfolio
Capital World Investors Los Angeles, CA

13.4M
Shares

$57.1 Million
0.01% of portfolio
Baillie Gifford & CO

10.4M
Shares

$44.2 Million
0.03% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

8.47M
Shares

$36.2 Million
0.01% of portfolio
Credit Suisse Ag Zurich, V8

4.55M
Shares

$19.4 Million
0.02% of portfolio

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $1.22B
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account